Cardiology

Retatrutide

Q: What does the research say about Retatrutide?

The scientific consensus on Retatrutide is unknown. No claims extracted for this topic Based on 0 analyzed claims.

Early-phase and translational research on retatrutide, a GLP-1/GIP/glucagon tri-agonist in development for obesity and metabolic disease.

Unknown pathwayAlso known as: Retatrutide, LY3437943, triple incretin agonist

Clinical questions

Evidence-backed

Claims analyzed

What does the research say about Retatrutide?

Unknown pathwayBased on 0 claims ( agreements, contradictions)

No claims extracted for this topic

New research on Retatrutide

Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial

Diabetes Obesity and Metabolism — Tonneijck L — Apr 2017

Current and Emerging Roles of GLP1 Receptor Agonists Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure

Biomolecules — Crispino S — Nov 2025

Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure

Diabetes and Vascular Disease Research — Mortada I — Jul 2026

Stay current on Retatrutide

Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.

Evidence brief: Retatrutide

Retatrutide (also known as Retatrutide, LY3437943, triple incretin agonist). Early-phase and translational research on retatrutide, a GLP-1/GIP/glucagon tri-agonist in development for obesity and metabolic disease.

As of 2026-08-14, the scientific consensus on Retatrutide is unknown. No claims extracted for this topic

This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-retatrutide.

Deterministic synthesis from Synapse's enriched corpus — 52 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.

Follow the latest Retatrutide research

Explore every Retatrutide paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.

Search Retatrutide papers